Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AGE

AgeX Therapeutics (AGE) Stock Price, News & Analysis

AgeX Therapeutics logo

About AgeX Therapeutics Stock (NYSE:AGE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$16.51
52-Week Range
N/A
Volume
3,700 shs
Average Volume
3,849 shs
Market Capitalization
$11.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AgeX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGE Stock News Headlines

Serina Therapeutics initiated with a Buy at JonesResearch
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Serina Therapeutics sells UniverXome subsidiary
Serina Therapeutics Inc (SER)
Serina Therapeutics to Present at the 14th Annual Injectables Summit
Russell Skibsted's Net Worth
See More Headlines

AGE Stock Analysis - Frequently Asked Questions

AgeX Therapeutics shares split on the morning of Monday, March 18th 2024.The 8-5 split was announced on Monday, March 18th 2024. The newly created shares were issued to shareholders after the closing bell on Monday, March 18th 2024. An investor that had 100 shares of stock prior to the split would have 160 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AgeX Therapeutics investors own include Allena Pharmaceuticals (ALNA), Biocept (BIOC), Palatin Technologies (PTN), Aadi Bioscience (AADI), Arbutus Biopharma (ABUS) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:AGE
CIK
1708599
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($13.0282)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.80 million
Net Margins
-10,424.65%
Pretax Margin
-10,430.28%
Return on Equity
N/A
Return on Assets
-120.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$140 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($16.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,080,000
Free Float
1,008,000
Market Cap
$11.99 million
Optionable
Not Optionable
Beta
1.18
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:AGE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners